why did the fda ban bpc-157 BPC 157 Banned: Key Facts on Latest Decision The FDA Is About to
Description
Using injections solely for low energy or aging-related decline is not supported by evidence and may expose patients to unnecessary risks
No adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers were observed
Not for injection, infusion, or any clinical application
This is critically important after surgery to prevent developing anemia (a low red blood cell count)
showed that daratumumab can reduce CD38 + Treg, Breg, and MDSC cell populations in ex vivo studies, while inducing helper and cytotoxic T cell expansion [44]
A dedicated preclinical safety evaluation reported that BPC-157 was well tolerated in mice, rats, rabbits, and dogs, with no serious toxicity observed under the tested conditions
